Neuroone Medical Technologies Corp
NMTC- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001500198
In the last 90 days, Neuroone Medical Technologies Corp insiders filed 1 open-market purchase and 0 sales; 26 institutions reported holding it in 13F filings for Q2 2026, worth $6.21M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Neuroone Medical Technologies Corp changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 12 | 11 | −1 |
| Shares | 2.12M | 1.84M | −278.1K (−13.1%) |
| Value | $2.33M | $1.51M | −$820.0K (−35.1%) |
New holders (3)
Institutions that held Neuroone Medical Technologies Corp at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kingsbury Capital Investment Advisors LLC | 53,403 | $44.0K | 0.06% |
| Tower Research Capital LLC (TRC) | 5,405 | $4.00K | 0.00% |
| UBS Group AG | 881 | $1.00K | 0.00% |
Sold out (4)
Institutions that held Neuroone Medical Technologies Corp at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Stonepine Capital Management, LLC | 248,105 | $273.0K |
| Susquehanna International Group, LLP | 34,777 | $38.0K |
| Virtu Financial LLC | 15,487 | $17.0K |
| FMR LLC | 43 | $0 |